135 related articles for article (PubMed ID: 27720203)
61. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
[TBL] [Abstract][Full Text] [Related]
62. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.
Galalae RM; Martinez A; Mate T; Mitchell C; Edmundson G; Nuernberg N; Eulau S; Gustafson G; Gribble M; Kovács G
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1048-55. PubMed ID: 15001244
[TBL] [Abstract][Full Text] [Related]
63. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
Huang K; D'Souza D; Patil N; Velker V; Leung E; Stitt L; Whiston F; Sugimoto A; McGee J; Prefontaine M
Brachytherapy; 2016; 15(5):543-8. PubMed ID: 27475479
[TBL] [Abstract][Full Text] [Related]
64. Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer.
Do L; Puthawala A; Syed N
Brachytherapy; 2009; 8(4):385-91. PubMed ID: 19733128
[TBL] [Abstract][Full Text] [Related]
65. Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.
Koontz BF; Chino J; Lee WR; Hahn CA; Buckley N; Huang S; Kim J; Reagan R; Joyner R; Anscher MS
Brachytherapy; 2009; 8(2):191-196. PubMed ID: 19433320
[TBL] [Abstract][Full Text] [Related]
66. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
[TBL] [Abstract][Full Text] [Related]
67. Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients' health quality perception.
Bourdais R; Achkar S; Espenel S; Bockel S; Chauffert-Yvart L; de Mellis FR; Ta MH; Boukhelif W; Durand-Labrunie J; Burtin P; Haie-Meder C; Deutsch E; Chargari C
J Contemp Brachytherapy; 2021 Jun; 13(3):263-272. PubMed ID: 34122565
[TBL] [Abstract][Full Text] [Related]
68. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy.
Andrews SF; Anderson PR; Eisenberg BL; Hanlon AL; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):475-80. PubMed ID: 15145165
[TBL] [Abstract][Full Text] [Related]
69. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
[TBL] [Abstract][Full Text] [Related]
70. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
[TBL] [Abstract][Full Text] [Related]
71. Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.
Bertin E; Benezery K; Kee DLC; François E; Evesque L; Gautier M; Gerard JP; Hannoun-Levi JM; Falk AT
J Contemp Brachytherapy; 2018 Dec; 10(6):522-531. PubMed ID: 30662475
[TBL] [Abstract][Full Text] [Related]
72. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
[TBL] [Abstract][Full Text] [Related]
73. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
74. High dose rate brachytherapy in the management of anal cancer: A review.
Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS
Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275
[TBL] [Abstract][Full Text] [Related]
75. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer.
Guinot JL; Baixauli-Perez C; Soler P; Tortajada MI; Moreno A; Santos MA; Mut A; Gozalbo F; Arribas L
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):165-71. PubMed ID: 25446608
[TBL] [Abstract][Full Text] [Related]
76. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.
Saarilahti K; Arponen P; Vaalavirta L; Tenhunen M
Radiother Oncol; 2008 Jun; 87(3):383-90. PubMed ID: 18501454
[TBL] [Abstract][Full Text] [Related]
77. Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis.
Arcelli A; Buwenge M; Macchia G; Cammelli S; Deodato F; Cilla S; Galuppi A; Panni V; Mattiucci GC; Tagliaferri L; Morganti AG
J Contemp Brachytherapy; 2019 Feb; 11(1):21-27. PubMed ID: 30911306
[TBL] [Abstract][Full Text] [Related]
78. The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation.
Reshko LB; Gaskins JT; Metzinger DS; Todd SL; Eldredge-Hindy HB; Silva SR
Brachytherapy; 2021; 20(1):75-84. PubMed ID: 33008762
[TBL] [Abstract][Full Text] [Related]
79. Pulsed dose rate (PDR) brachytherapy of anal carcinoma.
Roed H; Engelholm SA; Svendsen LB; Rosendal F; Olsen KJ
Radiother Oncol; 1996 Nov; 41(2):131-4. PubMed ID: 9004355
[TBL] [Abstract][Full Text] [Related]
80. Results from chemoradiotherapy for squamous cell cervical cancer with or without intracavitary brachytherapy.
Delgado D; Figueiredo A; Mendonça V; Jorge M; Abdulrehman M; de Pina MF
J Contemp Brachytherapy; 2019 Oct; 11(5):417-422. PubMed ID: 31749849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
